Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Sales | 1,280 | 810 | 560 | 490 | 450 |
| Gross Profit | 1,300 | 810 | 560 | 490 | 450 |
| Operating Expenses | 2,870 | 2,831 | 5,143 | 3,883 | 4,723 |
| Operating Income | -1,590 | -2,021 | -4,583 | -3,393 | -4,273 |
| Other Income | 20 | 21 | -7 | 63 | -67 |
| Pre-tax Income | -1,570 | -2,000 | -4,590 | -3,330 | -4,340 |
| Income Tax | 0 | 0 | 10 | -10 | 4 |
| Net Income Continuous | -1,570 | -1,990 | -4,610 | -3,320 | -4,340 |
| Net Income | $-1,570 | $-1,990 | $-4,610 | $-3,320 | $-4,340 |
| EBITDA(a) | $-1,500 | $-1,881 | $-4,433 | $-3,213 | $-4,063 |